# New Biomarkers and Plasma Prothrombotic Potential in Cardiac Transthyretin Amyloidosis

> **NCT06345235** · — · UNKNOWN · sponsor: **John Paul II Hospital, Krakow** · enrollment: 100 (estimated)

## Conditions studied

- Transthyretin Amyloidosis

## Interventions

- **DIAGNOSTIC_TEST:** blood test

## Key facts

- **NCT ID:** NCT06345235
- **Lead sponsor:** John Paul II Hospital, Krakow
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-07-11
- **Primary completion:** 2024-07-11
- **Final completion:** 2024-07-11
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06345235

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06345235, "New Biomarkers and Plasma Prothrombotic Potential in Cardiac Transthyretin Amyloidosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06345235. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*